Stock Events

Stock Events

Search...

Marker Therapeutics (MRKR) Q2 2025 Earnings

16MayConfirmed

Q2 2024

Q3 2024

Q4 2024

Q2 2025

-0.53

-0.44

-0.34

-0.25

Details

Expected EPS

-0.53017

Actual EPS

-0.4

Surprise EPS

0.13

Surprise Percent

+24.55%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.4 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.